Gahyun Gim

Internal Medicine
1600 SW Archer Rd
Gainesville, FL 32610

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Pancreatoblastoma: A Descriptive and Comparative Analysis with Pancreatic Ductal Adenocarcinoma Using SEER Data.

Pancreatoblastoma: A Descriptive and Comparative Analysis with Pancreatic Ductal Adenocarcinoma Using SEER Data.

Journal: Cancers
Published: May 19, 2026

Total Neoadjuvant Therapy with FOLFOX Followed by Short-Course Radiation in Locally Advanced Rectal Cancer-An Alternative Approach Evaluated in a Single-Center Clinical Trial.

Total Neoadjuvant Therapy with FOLFOX Followed by Short-Course Radiation in Locally Advanced Rectal Cancer-An Alternative Approach Evaluated in a Single-Center Clinical Trial.

Journal: Journal of clinical medicine
Published: March 11, 2026

Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.

Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.

Journal: The oncologist
Published: October 09, 2021

Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.

Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.

Journal: The oncologist
Published: August 05, 2021

Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis.

Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis.

Journal: Translational lung cancer research
Published: May 20, 2021

Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherapy as first-line therapy.

Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherapy as first-line therapy.

Journal: Heliyon
Published: April 18, 2021

Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).

Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).

Journal: Cancer immunology, immunotherapy : CII
Published: June 28, 2020
Showing 1-7 of 7

Last Updated: 09/26/2026